1989
DOI: 10.1007/bf00647237
|View full text |Cite
|
Sign up to set email alerts
|

Arterial chemotherapy and transcatheter arterial embolization therapy for non-resectable hepatocellular carcinoma

Abstract: An assessment was made on the therapeutic effects of arterial chemotherapy and transcatheter arterial embolization (TAE) therapy on 378 cases with non-resectable hepatocellular carcinoma (HCC). For the 191 cases who had undergone arterial chemotherapy, 22% had a 1-year survival rate, 8.9% survived for 2 years, and 4.0% for 3 years. Of these, for the 128 cases who were compatible with our criteria for patient selection, the three survival rates were 31.4%, 12.2% and 5.9% respectively. However, for the other 63 … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
31
0

Year Published

1991
1991
2017
2017

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 39 publications
(34 citation statements)
references
References 10 publications
0
31
0
Order By: Relevance
“…There is evidence that TACE is the preferred method to arrest tumor bleeding [13,[28][29][30][31][32][33][34] . Besides, two-stage hepatectomy is advisable because it can prolong the survival of selected patients [35][36][37][38][39][40] . Figure 4 is the logarithm about how to approach the patients with spontaneous ruptured HCC [35][36][37][38][39][40] .…”
Section: Discussionmentioning
confidence: 99%
“…There is evidence that TACE is the preferred method to arrest tumor bleeding [13,[28][29][30][31][32][33][34] . Besides, two-stage hepatectomy is advisable because it can prolong the survival of selected patients [35][36][37][38][39][40] . Figure 4 is the logarithm about how to approach the patients with spontaneous ruptured HCC [35][36][37][38][39][40] .…”
Section: Discussionmentioning
confidence: 99%
“…The variation in clinical presentations poses a challenge to clinicians in diagnosis and management. Various treatment options have been proposed, which include conservative treatment, 5 transarterial embolization (TAE), [6][7][8][9][10][11] different methods of operative hemostasis, 12,13 and emergency liver resection.…”
Section: Discussionmentioning
confidence: 99%
“…Owing to the poor result of surgical treatment, TAE was enthusiastically attempted but most of the reported series were small and the selection criteria used were uncertain. [6][7][8][9][10][11] Okazaki et al 9 described a larger series of patients in which the 1-month mortality in patients with a total bilirubin level of less than 51.3 ”mol/L (3.0 mg/dL) was 8.3% but was 86% in those with higher bilirubin levels. Chen et al 14 suggested immediate hepatectomy with an in-hospital mortality of 4.3% and a 5-year survival rate of 26.5%.…”
Section: Methodsmentioning
confidence: 99%
“…The overall probability of survival in the treated group was 64, 38, 27. and 27% at 1,2, 3, and 4 years, respective ly; that in the untreated group was 18, 6, and 5% at 1.2, and 3 years, respectively (p < 0.0001). A significant survial benefit of TACE was seen when compared with hepatic arterial chemotherapy [100,121 ] or systemic che motherapy [100]. Most reports are retrospective analyses, and comparisons between the numerous trials arc diffi cult to make because the disease is characterized by geo graphical variation in its natural history.…”
Section: Hepatocellular Carcinom a (Hcc)mentioning
confidence: 99%